Compositions and devices for removal of endotoxins and cytokines from fluids

Patent metadata

Field	Value
Publication number	US-11612681-B2
Application number	US-201816644782-A
Country	US
Kind code	B2
Filing date	Sep 6, 2018
Priority date	Sep 6, 2017
Publication date	Mar 28, 2023
Grant date	Mar 28, 2023

Abstract

Provided are sorption materials and devices using the sorption materials, and methods of using the sorption materials and devices containing the sorption materials. In various examples, the sorption materials bind to various inflammation stimulating and/or mediating molecules, which are often associated with systemic infections and systemic inflammation associated with conditions such as, for example, sepsis.

First claim

The invention claimed is:

1. A sorption material, comprising at least one compound bound to a porous solid substrate, wherein the compound has the following structure:
R 1 -L 1 -D-(L 2 -R 2 )x,y wherein R 1 is a bond or group attaching L 1 or D to the substrate;
L 1 and L 2 independently at each occurrence are optional and are linker groups;
D is a dendritic polymer moiety having one or more branched monomer units (X), and a plurality of end groups;
R 2 independently at each occurrence is an end group of the dendritic polymer;
x is the number of R 2 end groups that are charged moieties and range from 1-32; and y is the number of R 2 end groups that are each independently a lipophilic moiety or a hydrophobic moiety and range from 1-32.

2. A sorption material comprising at least one compound bound to a porous solid substrate, said compound having the following structure:
R 1 -L 1 -D-(L 2 -R 2 )x,y wherein R 1 is a bond or group attaching L 1 or D to the substrate;
L 1 and L 2 independently at each occurrence are optional and are linker groups;
D is a dendritic polymer moiety haying one or more branched monomer units (X), and a plurality of end groups;
R 2 independently at each occurrence is an end group of the dendritic polymer;
x is the number of R 2 end groups that are charged moieties and range from 1-32; and y is the number of R 2 end groups that are each independently a lipophilic moiety or a hydrophobic moiety and range from 1-32, wherein at least a portion of the substrate has size-exclusion pores with a molecular weight cutoff of less than or equal to 50 kDa.

3. A device for removing inflammation stimulating and/or mediating molecules from a fluid comprising: a housing defining an inlet and an outlet, wherein the inlet and the outlet are in fluid communication with one another, and the housing is configured such that the fluid enters the housing through the inlet and exits the housing through the outlet; and a sorption material is disposed in the housing, wherein the sorption material comprises at least one compound bound to a substrate, wherein the compound has the following structure:
R 1 -L 1 -D-(L 2 -R 2 ) x,y wherein R 1 is a bond or group attaching L 1 or D to the substrate;
L 1 and L 2 independently at each occurrence are optional and are linker groups;
D is a dendritic polymer moiety having one or more branched monomer units (X), and a plurality of end groups;
R 2 independently at each occurrence is an end group of the dendritic polymer;
x is the number of R 2 end groups that are charged moieties and range from 1-32; and
y is the number of R 2 end groups that are each independently a lipophilic moiety or a hydrophobic moiety and range from 1-32.

4. A method for treating a subject having or suspected of having a systemic infection and/or systemic inflammation comprising:
contacting a biological fluid containing one or more of an inflammation stimulating molecule and/or a mediating molecule from the subject with at least one sorption material, wherein the at least one sorption material comprises at least one compound bound to a substrate, wherein the compound has the following structure:
R 1 -L 1 -D-(L 2 -R 2 )x,y

wherein R 1 is a bond or group attaching L 1 or D to the substrate;
L 1 and L 2 independently at each occurrence are optional and are linker groups;
D is a dendritic polymer moiety having one or more branched monomer units (X), and a plurality of end groups;
R 2 independently at each occurrence is an end group of the dendritic polymer;
x is the number of R 2 end groups that are charged moieties and range from 1-32; and
y is the number of R 2 end groups that are each independently a lipophilic moiety or a hydrophobic moiety and range from 1-32, and
wherein at least a portion of or all of the one or more of or all of inflammation stimulating and/or mediating molecules bind to the sorption material.

5. The method of claim 4 , wherein the contacting comprises passing said biological fluid through a housing, wherein the housing includes an inlet and an outlet, wherein the inlet and the outlet are in fluid communication, and the housing is configured such that the fluid enters the housing through the inlet and exits the housing through the outlet, wherein the at least one sorption material is disposed in the housing.

6. The method of claim 4 , wherein the method further comprises returning the biological fluid to the subject.

7. The method of claim 4 , wherein the biological fluid is blood, serum, culture media, or a combination thereof.

8. The method of claim 4 , wherein the substrate is a hydrogel network or solid substrate.

9. The method of claim 8 , wherein the solid substrate is porous.

Assignees

• Univ New York State Res Found

Inventors

• Luo Juntao
• Wang Lili
• Shi Changying

Classifications

• C02F1/285

  using synthetic organic sorbents · CPC title

• B01J20/28054

  characterised by their surface properties or porosity · CPC title

• B01J20/3219

  involving a particular spacer or linking group, e.g. for attaching an active group · CPC title

• B01J20/3272

  Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds · CPC title

• C02F1/68

  by addition of specified substances, e.g. trace elements, for ameliorating potable water (medicinal water A61K) · CPC title